https://www.ms.ubc.ca/home daily 1.0 2022-02-28 https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623564524872-66SE0AHVOF2YDFVHU08I/UBC_20170327_3880.jpg About - Our Clinic. The UBC Hospital MS Clinic is recognized internationally for its unique and innovative approaches taken by clinical personnel and associated researchers; it has treated and followed over 10,000 patients since inception. Our Mandate. The mandate of the UBC Hospital MS Clinic has been a multidisciplinary team approach with the goal being “to find the cause and cure of MS through patient management and education, research and teaching." https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623565459237-36G97RKQKUSTQZBFK06U/unsplash-image-L9EV3OogLh0.jpg About - Research https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623565535309-R4IBE1PC6UA5XT5OMENM/unsplash-image-Ok76F6yW2iA.jpg About - Appointments https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623734961798-9T5D2RQBU0921EZOBDWO/unsplash-image-SpVHcbuKi6E.jpg About - Questions? https://www.ms.ubc.ca/history daily 0.75 2022-02-28 https://www.ms.ubc.ca/research daily 0.75 2021-10-20 https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623732671556-4VTDU6JSK8KYS86EPHCT/unsplash-image-L9EV3OogLh0.jpg Areas of Research - PATHOLOGY Ongoing exploration of the basic mechanisms of MS pathogenesis. The study of therapies with immunomodulatory as well as neuroprotective capabilities have the greatest promise in treating and preventing the disability attributed to inflammatory demyelination and neurodegeneration. Current projects apply molecular and cellular techniques in cell based and disease models to study the relative contributions of inflammatory cells and mediators to disease development (Jacqueline Quandt) in addition to the study of the Blood Brain Barrier (Katerina Dorivini-Zis). https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623733207640-RRQ88DW9YKWE527ZFERJ/unsplash-image-L7en7Lb-Ovc.jpg Areas of Research - IMMUNOLOGY Study of antibody secretion in vitro using both myasthenia gravis and MS as models and the development of assays to measure antibodies to interferon in MS (Joel Oger). The study of whether autoimmunity to lipid antigens plays a role in the pathophysiology of disease such as multiple sclerosis. https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623732496940-TBEHRI07VBEP61A73SBH/MRI+Brain.jpeg Areas of Research - MS/MRI RESEARCH GROUP (MRI) The MS MRI Research Group (David Li, Tony Traboulsee) designs multicentre clinical trial protocols for MRI and central MRI analysis. MS/MRI is a multi-disciplinary group of neurologists, radiologists, computer programmers, statisticians and scientists working together to design MRI protocols for use in phase I, II, III and IV multicenter clinical trials in MS. The MS/MRI Research Group is focused on developing better trial methodologies to improve the lives of people with neurological diseases. https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623733326092-L6L67QA7AUEY8Z3LSINU/unsplash-image-XknuBmnjbKg.jpg Areas of Research - GENETICS Research on genetic susceptibility to MS has been a very productive and successful part of the MS program (Dessa Sadovnick) in addition to studying epidemiology, pathobiology, and the clinical outcome of Canadian children with clinically isolated demyelinating syndromes (CIS). https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623734207333-TCK0P1DTLMI3LN1LK5F1/unsplash-image-ysv6k_gPOZM.jpg Areas of Research - EPIDEMIOLOGY Ongoing investigation of possible underlying factors driving disease progression from genes to the environment (Helen Tremlett). A core component of this program focuses on bringing together, for the first time, multiple large health databases created for over two decades by physicians, pharmacists and allied healthcare professionals. Ultimate aim is to improve the health, treatment options and outcome for people and families living with MS. https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1623734478492-RICMNLUFPPQQTL6R9NH4/unsplash-image-s9CC2SKySJM.jpg Areas of Research - REHABILITATION & OCCUPATIONAL THERAPY Research in chronic neurological conditions and their impact on chosen occupations (Susan Forwell). Current projects include research investigating occupations related to significant life transitions, community integration, and health and well being; fatigue in multiple sclerosis (MS); pain and fatigue in spinal cord injury (SCI); fatigue in traumatic brain injury (TBI); and adults successfully living with MS. https://www.ms.ubc.ca/contact daily 0.75 2022-02-28 https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1627332796114-2KYJ6TAUO3RXO994GGZR/MRI%2BBrain.jpg Contact https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/56a716d0-90b4-46a6-9589-d70e529d08a7/foyer+image.jpg Contact https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/61e9e3c4-c568-49e1-9046-ad680797e462/UBC_20170327_4565.jpg Contact https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1646081041527-UONRF2K48RDDFGZBOA7C/unsplash-image-SpVHcbuKi6E.jpg Contact - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.ms.ubc.ca/training daily 0.75 2022-02-28 https://www.ms.ubc.ca/our-team daily 0.75 2024-11-14 https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/905a8f1a-e7a1-48f4-b681-21a3cc94aca8/IMG_3810+cropped+copy.png Our Team - DR. VIRGINIA DEVONSHIRE Dr. Virginia Devonshire is the Director of the UBC MS/NMO Clinic and the University of Northern BC MS Clinic. She is also the Director of the UBC MS/NMO Clinical Trials group, where she has been Principal Investigator on numerous trials. She has published in various areas of MS therapeutics, the natural history of MS and pregnancy in MS. She is an Associate Clinical Professor at the University of British Columbia and Director of the MS Fellowship program and involved in resident and medical school teaching and mentorship. She is the current President of the Canadian Network of MS Clinics. https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/06544f73-0ce7-4c91-861f-74e48b502f6e/traboulsee+edit.png Our Team - DR. ANTHONY TRABOULSEE Anthony Traboulsee is a Professor and Research Chair of the MS Society of Canada at the University of British Columbia and is Director of the MS/MRI Research Group. He received his B.Sc. from McGill University in Montreal, Canada and his M.D. from Dalhousie University in Halifax, Nova Scotia. He completed a residency in Neurology and fellowship in Multiple Sclerosis at the University of British Columbia Hospital in Vancouver and University College London (Queen Square). His research focus is on the development of practice guidelines for routine use of MRI in the management of MS, establishing advanced MRI imaging outcomes in Multiple Sclerosis, and the treatment of Neuromyelitis Optica. https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/41c88405-0a60-44f9-8d68-f680e755d9ca/download.jpg Our Team - DR. ANA-LUIZA SAYAO Ana-Luiza Sayao, BSc, MD, FRCPC, is currently a Neurologist at St. Paul’s Hospital and the University of British Columbia Multiple Sclerosis Clinic. She completed her residency training at UBC and Royal College board certification in Neurology in 2009. She then completed a Fellowship in Multiple Sclerosis at UBC in 2010. She is the adult Neurology Lead in the BC Pediatric Transition Care Project where she and colleagues are creating transition care plans for young persons with neurological disorders including Multiple Sclerosis and other Neuro-inflammatory conditions. She is currently an Assistant Clinical Professor at UBC. https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/b316381c-c369-4d7f-9ec7-1759f9ecf4c2/IMG_4038+cropped.png Our Team - DR. ROBERT CARRUTHERS Originally from Vancouver, Dr. Carruthers studied medicine at the Tulane University School of Medicine. He did his internship at Massachusetts General Hospital, followed by neurology residency at the combined Brigham and Women’s Hospital/Massachusetts General Hospital program. He then undertook a fellowship in Multiple Sclerosis at the Partners MS Center at Brigham and Women’s Hospital. His interests include improving patient care and safety in MS, Neuromyelitis Optica and neuroimmunology. https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/b53f25a5-2cbf-407a-b898-ac293cdb4e35/IMG_3872+copy.png Our Team - DR. ALICE SCHABAS Dr. Alice Schabas is a clinical neurologist specializing in the care of patients with Multiple Sclerosis. She completed her medical education at Queen’s University in Kingston, Ontario. Following that, she did her neurology residency training here in Vancouver. Finally, she completed a fellowship in Multiple Sclerosis at the University of British Columbia. Her interests include: quality improvement for enhanced patient care and symptomatic management for patients with Multiple Sclerosis. https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/f7dee917-2bed-493b-9c96-c522e21d6e52/Clinic+nurses+copy.png https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/49f0e73d-21c0-46ee-b55d-820a21ae3e11/Clerks+copy.png https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/dc536c3f-a6c3-49b5-ab2d-86cf68a9eca6/Research+nurses.png https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/96e09299-d32f-4be1-a762-c7531db534fe/IMG_4204.jpg https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/b048233a-9fa2-4bc0-a749-8b51b3c264fe/michelle+and+denise+copy.png https://www.ms.ubc.ca/appointments daily 0.75 2022-12-08 https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1618497259178-6XJGK9GR6YAVBQL5L519/20140301_Trade-151_012-2.jpg Appointments https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1607694583486-2PQT0LQ193RL7MCB6DX4/20140228_Trade+151_0046.jpg Appointments https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1607694644871-IC85FNH781UNZSZEGHDR/Aro+Ha_0428.jpg Appointments https://www.ms.ubc.ca/clinical-trials daily 0.75 2026-04-28 https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1670480826711-41JP05FUTHCHBFINJHPU/unsplash-image-lQGJCMY5qcM.jpg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1627332796114-2KYJ6TAUO3RXO994GGZR/MRI%2BBrain.jpg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1627334008891-XPY87IYT524VLQAYGK4E/unsplash-image-pwcKF7L4-no.jpg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1627333178542-79GL5Q5I06QEJUK4XV6F/unsplash-image-OQMZwNd3ThU.jpg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1627333091057-ZM8SF2GTUBDRWRFBUYIE/unsplash-image-7wWRXewYCH4.jpg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1712018264591-SHD5M5F7DJRQCD3SCE0P/image-asset.jpeg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1712018441264-OFF5H6CF27RRAQXQGIG3/image-asset.jpeg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1712018614480-13S7QVALG8IAOH4PD441/image-asset.jpeg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1769200211085-CV41ANS2ZUQWEFWB0W32/image-asset.jpeg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1769200657901-RE2J61FZAUAO5K3GNZK0/unsplash-image-921tXrKQJSA.jpg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1769201290538-6UBJT6HVJD6WFWFMYGLY/unsplash-image-yJn0zZdFIwU.jpg Clinical Trials https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1777403243429-H5SICZJZ15USNH9DLJ0V/unsplash-image-65F0f5Pn80M.jpg Clinical Trials https://www.ms.ubc.ca/donations daily 0.75 2022-12-08 https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1627575561343-6KDUE4XTCV3J3TQNPB17/5NarrowLogo_ex_768.png Donations https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1627575635812-8BBFKULX162U5CYA1EVZ/VGHFoundation-logo-web.png Donations https://www.ms.ubc.ca/nmo daily 0.75 2022-12-08 https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1646074759538-S04WRMOSQTT4IM78XA2N/Screen+Shot+2022-02-28+at+10.58.58+AM.png NMO https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/1646075154863-4FPTLVWFI901F3YLPDUQ/foyer+image.jpeg NMO https://images.squarespace-cdn.com/content/v1/60c5977c37f0f1662ee94ac4/51e5ee11-e96e-4f44-b1dc-12d67a708f9e/anthony-traboulsee-patient-clinic-scaled.jpg NMO - Goals of our Clinic The overall goal of our clinic is to model ethical and responsible professional behaviour while providing medical treatment to a diverse patient population which meets the standard of care. Our specific goals are to: Improve the accuracy of NMO diagnosis Start preventative treatment as early as possible and treat severe relapses rapidly Research NMO to improve our understanding and develop new preventative treatments Educate patients, families and healthcare professionals about NMO Advocate with government, hospitals and the MS Society for NMO resources Establish national guidelines for NMO treatment https://www.ms.ubc.ca/patient-resources daily 0.75 2024-02-03 https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1618497259178-6XJGK9GR6YAVBQL5L519/20140301_Trade-151_012-2.jpg Patient Resources https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1607694583486-2PQT0LQ193RL7MCB6DX4/20140228_Trade+151_0046.jpg Patient Resources https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1607694644871-IC85FNH781UNZSZEGHDR/Aro+Ha_0428.jpg Patient Resources https://www.ms.ubc.ca/clinical-trials-1 daily 0.75 2023-06-14